Contineum Therapeutics, Inc. - Common Stock, $0.001 par value (CTNM)

CUSIP: 21217B100

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
+271,847
SEC-reported price per share
$13.42
Number of holders
19
Value change
+$3,623,752
Number of buys
15
Number of sells
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,342,375

Security key

21217B100

Report period

Q3 2026

Institutions

19

Top holders

10

Ownership snapshot

Top reported holders of CTNM - Contineum Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
MONTANOVA CAPITAL, LLC
Comparable rows
10/15
Latest evidence
30 Sep 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.9% 5 rows are not safely comparable across share classes. 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 7.9%.

10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 7.9%
Janus Henderson Group Ltd. 7.9%
BALYASNY ASSET MANAGEMENT L.P. 7.1%
BlackRock, Inc. 6.3%
FRANKLIN TEMPLETON INC 5.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13D/G 13F
Company
7.9%
Reported 13D/G · 30 Sep 2026
$34,403,062
2,610,248 shares
$0 30 Sep 2026
Janus Henderson Group Ltd.
13D/G
JANUS HENDERSON GROUP PLC
7.9%
Reported 13D/G · 31 Dec 2025
$27,991,830
2,448,979 shares
$0 31 Dec 2025
BALYASNY ASSET MANAGEMENT L.P.
13D/G 13F
Company
7.1%
Reported 13D/G · 30 Jun 2026
$35,477,004
2,335,550 shares
-$1,248,208 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
6.3%
Reported 13D/G · 30 Jun 2026
$33,834,614
2,064,345 shares
— 30 Jun 2026
FRANKLIN TEMPLETON INC
13F 13D/G
Company
5.2%
Reported 13D/G · 30 Sep 2026
$30,144,931
1,839,227 shares
— 30 Jun 2026
Trails Edge Capital Partners, LP
13D/G
5.1%
Reported 13D/G · 22 Sep 2026
$22,538,125
1,679,443 shares
$0 22 Sep 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
19
Shares
3,870,542
Rows available
19
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
102
Q3 2026 holders
19
Holder diff
-83
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .